Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 2,691 | 1,025 | 186 | 60 | 0 |
| Gross Profit | 2,691 | 1,025 | 186 | 60 | N/A |
| Operating Expenses | 28,272 | 23,499 | 18,403 | 18,403 | 0 |
| Operating Income | -25,581 | -22,474 | -18,217 | -18,343 | N/A |
| Other Income | -185 | -1,399 | -726 | -81 | 0 |
| Pre-tax Income | -25,766 | -23,873 | -18,943 | -18,424 | 0 |
| Net Income Continuous | -25,766 | -23,873 | -18,943 | -18,424 | N/A |
| Net Income | $-25,766 | $-23,873 | $-18,943 | $-18,424 | $N/A |
| EPS Basic Total Ops | -1.17 | -1.09 | -0.88 | -0.85 | N/A |
| EPS Basic Continuous Ops | -1.17 | -1.09 | -0.87 | -0.85 | N/A |
| EPS Diluted Total Ops | -1.17 | -1.09 | -0.88 | -0.85 | N/A |
| EPS Diluted Continuous Ops | -1.17 | -1.09 | -0.87 | -0.85 | N/A |
| EBITDA(a) | $-24,456 | $-21,617 | $-17,193 | $-17,406 | $N/A |